Trademark Attorney / Law Firm
MICHAEL GEORGE KOUSKOUTIS – Trademark Portfolio
MICHAEL GEORGE KOUSKOUTIS specializes in Class 41 (Education & Entertainment) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 3 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 2 other Nice Classification classes. Filing activity spans from 2025 to 2026. Currently, 1 trademark is registered and 1 is pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
MICHAEL GEORGE KOUSKOUTIS's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has MICHAEL GEORGE KOUSKOUTIS filed?
MICHAEL GEORGE KOUSKOUTIS has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 pending, 1 abandoned.
What trademark classes does MICHAEL GEORGE KOUSKOUTIS specialize in?
MICHAEL GEORGE KOUSKOUTIS has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
How long has MICHAEL GEORGE KOUSKOUTIS been filing trademarks?
MICHAEL GEORGE KOUSKOUTIS's trademark filing history with the USPTO spans from 2025 to 2026, covering 1 year of trademark practice. During this period, MICHAEL GEORGE KOUSKOUTIS has handled 3 trademark applications.
What is MICHAEL GEORGE KOUSKOUTIS's trademark registration success rate?
MICHAEL GEORGE KOUSKOUTIS has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.